BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 9448324)

  • 41. Congenital myasthenic syndrome caused by a mutation in the Ets-binding site of the promoter region of the acetylcholine receptor epsilon subunit gene.
    Ohno K; Anlar B; Engel AG
    Neuromuscul Disord; 1999 May; 9(3):131-5. PubMed ID: 10382905
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Opposing effects of Ets and Id proteins on p16INK4a expression during cellular senescence.
    Ohtani N; Zebedee Z; Huot TJ; Stinson JA; Sugimoto M; Ohashi Y; Sharrocks AD; Peters G; Hara E
    Nature; 2001 Feb; 409(6823):1067-70. PubMed ID: 11234019
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Transcriptional control of the neuronal nicotinic acetylcholine receptor gene cluster by the beta43' enhancer, Sp1, SCIP and ETS transcription factors.
    Deneris ES; Francis N; McDonough J; Fyodorov D; Miller T; Yang X
    Eur J Pharmacol; 2000 Mar; 393(1-3):69-74. PubMed ID: 10770999
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Neu differentiation factor stimulates phosphorylation and activation of the Sp1 transcription factor.
    Alroy I; Soussan L; Seger R; Yarden Y
    Mol Cell Biol; 1999 Mar; 19(3):1961-72. PubMed ID: 10022883
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Transactivation of GATA-1 promoter with ETS1, ETS2 and ERGB/Hu-FLI-1 proteins: stabilization of the ETS1 protein binding on GATA-1 promoter sequences by monoclonal antibody.
    Seth A; Robinson L; Thompson DM; Watson DK; Papas TS
    Oncogene; 1993 Jul; 8(7):1783-90. PubMed ID: 8510925
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Identification of an element required for acetylcholine receptor-inducing activity (ARIA)-induced expression of the acetylcholine receptor epsilon subunit gene.
    Si J; Miller DS; Mei L
    J Biol Chem; 1997 Apr; 272(16):10367-71. PubMed ID: 9099674
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Targeting transcription to the neuromuscular synapse.
    Schaeffer L; de Kerchove d'Exaerde A; Changeux JP
    Neuron; 2001 Jul; 31(1):15-22. PubMed ID: 11498047
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Functional synergism of STAT6 with either NF-kappa B or PU.1 to mediate IL-4-induced activation of IgE germline gene transcription.
    Stütz AM; Woisetschläger M
    J Immunol; 1999 Oct; 163(8):4383-91. PubMed ID: 10510379
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Identification of a second promoter in the human c-ets-2 proto-oncogene.
    Bègue A; Crepieux P; Vu-Dac N; Hautefeuille A; Spruyt N; Laudet V; Stehelin D
    Gene Expr; 1997; 6(6):333-47. PubMed ID: 9495315
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Regulation by ARIA/neuregulin of acetylcholine receptor gene transcription at the neuromuscular junction.
    Si J; Tanowitz M; Won S; Mei L
    Life Sci; 1998; 62(17-18):1497-502. PubMed ID: 9585125
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Involvement of Ets, rel and Sp1-like proteins in lipopolysaccharide-mediated activation of the HIV-1 LTR in macrophages.
    Sweet MJ; Stacey KJ; Ross IL; Ostrowski MC; Hume DA
    J Inflamm; 1998; 48(2):67-83. PubMed ID: 9656143
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Regulation of urokinase expression in the developing avian heart: a role for the Ets-2 transcription factor.
    Majka SM; McGuire PG
    Mech Dev; 1997 Nov; 68(1-2):127-37. PubMed ID: 9431810
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Oncogenic Ras can induce transcriptional activation through a variety of promoter elements, including tandem c-Ets-2 binding sites.
    Galang CK; Der CJ; Hauser CA
    Oncogene; 1994 Oct; 9(10):2913-21. PubMed ID: 8084596
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Inhibitory roles for SHP-1 and SOCS-3 following pituitary proopiomelanocortin induction by leukemia inhibitory factor.
    Bousquet C; Susini C; Melmed S
    J Clin Invest; 1999 Nov; 104(9):1277-85. PubMed ID: 10545526
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Neuregulin-1 induces expression of Egr-1 and activates acetylcholine receptor transcription through an Egr-1-binding site.
    Fromm L; Rhode M
    J Mol Biol; 2004 Jun; 339(3):483-94. PubMed ID: 15147836
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Role of Ets2 in cyclic AMP regulation of the human chorionic gonadotropin beta promoter.
    Johnson W; Jameson JL
    Mol Cell Endocrinol; 2000 Jul; 165(1-2):17-24. PubMed ID: 10940479
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The c-Ets oncoprotein activates the stromelysin promoter through the same elements as several non-nuclear oncoproteins.
    Wasylyk C; Gutman A; Nicholson R; Wasylyk B
    EMBO J; 1991 May; 10(5):1127-34. PubMed ID: 1850695
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Transcriptional repressor ERF is a Ras/mitogen-activated protein kinase target that regulates cellular proliferation.
    Le Gallic L; Sgouras D; Beal G; Mavrothalassitis G
    Mol Cell Biol; 1999 Jun; 19(6):4121-33. PubMed ID: 10330152
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Neural regulation of muscle acetylcholine receptor epsilon- and alpha-subunit gene promoters in transgenic mice.
    Gundersen K; Sanes JR; Merlie JP
    J Cell Biol; 1993 Dec; 123(6 Pt 1):1535-44. PubMed ID: 8253848
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Essential role of the transcription factor Ets-2 in Xenopus early development.
    Kawachi K; Masuyama N; Nishida E
    J Biol Chem; 2003 Feb; 278(7):5473-7. PubMed ID: 12468533
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.